Durgical
EN
Open the app

Glycaemic targets, HbA1c and continuous glucose monitoring

  • Follow-up and treatment

There is no single «good sugar» for everyone. A fit 40-year-old and a frail 85-year-old need different targets, and a sensor shows what HbA1c hides.

Updated

What it is

HbA1c reflects the average glucose of the past two to three months. For most non-pregnant adults the target is below 7% (53 mmol/mol); a lower target (below 6.5%) suits some young patients if it can be reached without hypoglycaemia, and a higher one (below 8%) suits people with limited life expectancy, frailty, advanced complications or a history of severe hypoglycaemia. Day-to-day control is checked by capillary glucose (usual targets before meals 80–130 mg/dL and below 180 mg/dL one to two hours after eating) or by continuous glucose monitoring (CGM), which measures interstitial glucose every few minutes. CGM is summarised as time in range (70–180 mg/dL; target more than 70% of the day), time below range (below 70 mg/dL less than 4%, below 54 mg/dL less than 1%) and time above range, and it is recommended for everyone on insulin.

What to know

  • Targets are individual: younger, healthy, short duration, no hypoglycaemia → lower target; frail, short life expectancy, severe hypoglycaemia, advanced complications → higher target.
  • Older adults: healthy with few illnesses, below 7.0–7.5%; complex or intermediate health, below 8.0%; very complex or poor health, avoid hypoglycaemia and symptomatic hyperglycaemia rather than aiming at a number.
  • Pregnancy: tighter targets (below 6% if reachable without hypoglycaemia, otherwise below 7%), because the fetus is exposed to every high.
  • Children and adolescents: below 7% for most, with CGM metrics as for adults.
  • An HbA1c of 7% corresponds to an average glucose of about 154 mg/dL (8.6 mmol/L).
  • CGM targets for most adults: time in range above 70%, time below 70 mg/dL under 4%, below 54 mg/dL under 1%, above 180 mg/dL under 25%; for older or high-risk adults, time in range above 50% and time below 70 mg/dL under 1%.
  • Glucose variability (coefficient of variation) at or below 36% marks stable control.
  • The glucose management indicator (GMI) is an HbA1c estimated from CGM; a gap between GMI and laboratory HbA1c suggests a red-cell or haemoglobin problem.
  • HbA1c is unreliable in anaemia, haemoglobin variants, recent transfusion or bleeding, pregnancy and advanced kidney disease: use glucose or CGM instead.
  • Sensor readings lag blood glucose by several minutes, most when glucose changes fast; confirm with a fingerstick when symptoms and the sensor disagree.

Choosing the HbA1c target

PatientUsual HbA1c targetMain concern
Most non-pregnant adultsBelow 7%Prevent small-vessel complications
Young, healthy, short duration, no hypoglycaemiaBelow 6.5% if safeLong life ahead to accumulate damage
Healthy older adultBelow 7.0–7.5%Balance benefit and hypoglycaemia
Frail, many illnesses, short life expectancy, severe hypoglycaemiaBelow 8%, or avoid symptomsHypoglycaemia, falls, burden of treatment
PregnancyBelow 6% if safe, otherwise below 7%Fetal exposure to hyperglycaemia

In the clinic

  • A falling HbA1c with new night-time confusion in an older patient is not a success: look for hypoglycaemia with CGM or night checks.
  • A high HbA1c with normal fingerstick readings suggests the patient tests only at good moments, a meter problem, or high readings after meals that are never checked.
  • People with type 2 diabetes on non-insulin drugs that do not cause hypoglycaemia rarely need daily fingersticks; testing is useful when starting or changing treatment, during illness, or to learn food effects.

Next step / Initial management

  • HbA1c every three months when not at target or after a change in treatment, and at least twice a year when stable.
  • Agree an individual HbA1c target with each patient and write it in the record; review it as health changes.
  • Offer CGM to everyone on insulin; review the ambulatory glucose profile at each visit, looking first at time below range, then time in range.
  • When HbA1c and glucose readings disagree, check haemoglobin, kidney function and haemoglobin variants, and rely on glucose or CGM.
  • Refer to endocrinology persistent time below range despite changes, hypoglycaemia unawareness, or pregnancy with diabetes.

Common traps

  • Lower HbA1c is always better: below an individual target, extra lowering mainly adds hypoglycaemia, and in frail or older patients that raises falls and deaths.
  • An HbA1c at target means control is fine: the same average can hide frequent lows and highs, which only CGM or structured testing shows.
  • Sensor and fingerstick should match exactly: interstitial glucose lags blood glucose, most when it is changing fast after meals or exercise.
  • HbA1c works the same in everyone: anaemia, haemoglobin variants, pregnancy and kidney failure shift it independently of glucose.
  • Time in range above 70% is the target for every adult: for older and high-risk adults the priority is time below range, so a lower time in range is accepted.

Test yourself

Think of the answer, then tap the question to see it.

An 84-year-old with dementia on insulin has an HbA1c of 6.4% and recent falls. What do you do with the target?

Relax it: for very complex health the goal is avoiding hypoglycaemia and symptoms, not a low number. Simplify treatment and check for lows.

Two patients have an HbA1c of 7.2%. One has a time in range of 80%, the other 45% with 8% below range. Who needs urgent change?

The second: the same average hides frequent highs and dangerous lows. Time below range above 4% needs treatment changed first to prevent severe hypoglycaemia.

A patient's CGM indicator (GMI) is 7.8% but the laboratory HbA1c is 6.2%. What might explain it?

A shortened red-cell lifespan (haemolysis, bleeding, kidney disease with erythropoietin) or a haemoglobin variant falsely lowering HbA1c.

Add to my cards (3)

Elsewhere in DurgiPedia

Connections

← All of endocrinology

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: Hemoglobin A1C (StatPearls (NCBI Bookshelf), 2025); Type 2 Diabetes (StatPearls (NCBI Bookshelf), 2023); Type 1 Diabetes (StatPearls (NCBI Bookshelf), 2024); Hypoglycemia (StatPearls (NCBI Bookshelf), 2022).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.